Tag results:
reporter assay
Pancreatic Cell News
The Inhibitory Effect of LINC00261 Upregulation on the Pancreatic Cancer EMT Process Is Mediated by KLF13 via the mTOR Signaling Pathway
[Clinical and Translational Oncology] The location of LINC00261 in PC cells was identified by RNA fluorescence in situ hybridization (RNA-FISH).
Cancer Stem Cell News
Increased Expression of PD-L1 in Endometrial Cancer Stem-Like Cells Is Regulated by Hypoxia
[Frontiers in Bioscience-Landmark] Using flow cytometry and western blot assays, the authors have demonstrated that programmed cell death ligand 1 expression is higher in endometrial cancer stem-like cell derived from endometrial cancer than in nonstem-like cancer cells.
Endothelial Cell News
CircCHMP5 Contributes to Ox-LDL-Induced Endothelial Cell Injury through the Regulation of MiR-532-5p/ROCK2 Axis
[Cardiovascular Drugs and Therapy] Oxidized low-density lipoprotein was used to treat human umbilical vein endothelial cells to construct a cell injury model. The expression level of circCHMP5, miR-532-5p, and Rho-associated protein kinase 2 was measured using quantitative real-time PCR.
Muscle Cell News
LncRNA XR_596701 Protects H9c2 Cells against Intermittent Hypoxia-Induced Injury through Regulation of the miR-344b-5p/FAIM3 Axis
[Cell Death Discovery] Gene expressions of XR_596701 and miR-344b-5p were detected by quantitative real-time polymerase chain reaction in intermittent hypoxia-induced H9c2 cells.
Muscle Cell News
LncRNA ROR Modulates Myocardial Ischemia-Reperfusion Injury Mediated by the miR-185-5p/CDK6 Axis
[Laboratory Investigation] Researchers revealed that hypoxia/reoxygenation (H/R) treated human cardiac myocytes showed a significantly decreased miR-185-5p expression and increased expression of CDK6 and ROR.
Cancer Stem Cell News
Tanshinone IIA Attenuates the Stemness of Breast Cancer Cells via Targeting the miR-125b/STARD13 Axis
[Experimental Hematology & Oncology] In vitro mammary spheroid formation, flow cytometry assay on CD24−/CD44+ sub-population, ALDH activity detection, cell viability assay and western blot analysis, and in vivo tumor-initiating analysis were performed to examine the effects of Tanshinone IIA on the stemness of breast cancer cells.